Translate this page into:
Lattice corneal dystrophy: Visual outcomes with scleral lens
-
Received: ,
Accepted: ,
How to cite this article: Balakrishnan M. Lattice corneal dystrophy: Visual outcomes with scleral lens. J Ophthalmic Res Pract. doi: 10.25259/JORP_36_2025
Abstract
Lattice corneal dystrophy (LCD) is a rare, bilateral, inherited disorder characterized by the deposition of amyloid fibrils in the corneal stroma, leading to progressive vision impairment. This condition results in recurrent corneal erosions, stromal haze, and corneal thinning, ultimately affecting visual acuity (VA). The management of LCD primarily aims to alleviate symptoms and delay progression, with treatment options ranging from lubricating eye drops to corneal transplantation in advanced cases. This case report illustrates scleral lenses (SL) as an effective non-surgical intervention for improving visual function in LCD patients. SL vaults over the cornea, protecting the fragile corneal epithelium. SL helps mitigate symptoms such as photophobia and recurrent erosions by maintaining corneal hydration and reducing mechanical trauma. Their ability to improve VA and delay the need for surgical intervention makes them a valuable therapeutic option in managing LCD. Further research is needed to optimize lens designs and evaluate long-term outcomes in LCD patients.
Keywords
Aberrations
Lattice corneal dystrophy
Photophobia
Scleral lens
Vision
Refractive aspect of scleral lens in lattice corneal dystrophy

INTRODUCTION
Lattice corneal dystrophy (LCD) is a rare, inherited condition that primarily affects the cornea of the eye, leading to progressive vision loss due to the accumulation of amyloid deposits. These deposits appear in a distinctive “lattice-like” pattern, hence the name, and are typically located in the central part of the cornea, while the peripheral cornea tends to remain unaffected. The amyloid deposits disrupt the corneal structure, leading to opacity and diminishing the clarity of vision over time.
Type I LCD, also known as Biber-Haab-Dimmer dystrophy. It is autosomal dominant and results from mutations in the transforming human growth factor beta-induced (TGFBI) gene. It is usually present in the first or second decade of life.[1,2] LCD type I is caused by mutations in the TGFBI gene, located on chromosome 5 at locus 5q31.[1,2] This gene is also called BIGH3.[3,4]
Scleral lenses (SL) are designed to vault over the entire corneal surface, resting on the sclera. These lenses offer correction of visual symptoms caused by a variety of ocular surface diseases and corneal ectasias. A fluid reservoir (FR) forms between the lens and the cornea, smoothing surface irregularities, providing relief for those with ocular surface disease, and allowing for healing of the ocular surface. Primary indications for use of SL includes ocular surface disease, corneal irregularity, and severe refractive error.
CASE REPORT
A 40-year-old male presented with chief complaints of diminution of vision, photophobia and a history of LCD Type I (LCDI). The patient reported working as a data Analyst. Before arrival, he had been advised of penetrating keratoplasty (PK) from a corneal specialist. The patient was adamant about avoiding surgery, yet had extremely specific standards for his visual performance. On presentation, the patient’s uncorrected visual acuity was 6/60 eff in both eyes, and best corrected visual acuity was 6/24 with +3.50D in OD and 6/24 with +3.00 Ds in OS. Slit-lamp examination of both eyes (OU) reveals lattice-like lines in the stromal layer that spread from the central cornea toward the periphery, suggestive of LCD [Figure 1a]. Anterior-segment optical coherence tomography was performed to confirm the disruptions in the Bowman’s and anterior stromal layers, and pachymetry revealed OD:618 microns, OS:648 microns, showing increased thickness and diagnosed as LCD Type I [Figure 1b]. The patient was educated that disease progression had occurred and would likely continue. Additional education included the possibility of PK and LL with ECCC/IOL+ in the future, but he was reassured that the best vision and comfort would be found using SL. The patient was then fitted with a 16.50 mm SL, which was vaulting the cornea with 2.8 sag in OU [Figure 2]. Adequate central vault of around 300 microns, good coverage, centration with good haptics of no blanching and edgelift were achieved, with which the patient’s visual acuity (VA) was 6/7.5 in OU, also photophobia was reduced with good comfort. The patient was very much motivated for SL in OU.


DISCUSSION
The symptoms of corneal dystropy bascially depends on which specific type you have. Few candidates never have any symptoms at all. However, when symptoms develop, they usually affect both eyes and progressively get worse with time. The cornea, likely a meticulously crafted piece of glass, plays a pivotal role in how we see the world. Its clarity and curvature are essential for refracting light properly onto the retina, enabling sharp vision. However, corneal dystrophies can change that, however, they disrupt this delicate equilibrium. These are often genetic conditions that lead to the accumulation of abnormal materials, whether lipids, proteins, or other deposits in the cornea’s layers. Corneal dystrophies, however, disrupt this delicate equilibrium. These are often genetic conditions that lead to the accumulation of abnormal materials such as lipids, proteins, or other deposits, in the cornea’s layers. That makes symptoms such as as the corneal deposits increase, they can scatter light passing through the cornea, resulting in blurry or distorted vision, photophobia associated with deposits, and structural changes in the cornea. In addition to the lattice-like opacities, recurrent epithelial erosions are a common complication of LCD. These erosions occur when the outermost layer of the cornea (the epithelium) becomes damaged, causing pain, irritation, and further vision impairment. These erosions can appear even before the characteristic stromal deposits become noticeable, adding to the challenges of early diagnosis,[1,3,5-7] corneal surface irregularities may lead to gritty sensation. Surface irregularities lead to higher order aberrations (HOAs) where patients complain of halos, glare, ghost images, and difficulty during night drives. Previous studies have reported the utilization of SL in improving VA,[8,9] Contrast sensitivity,[10,11] and reducing HOAs[11,12] in irregular or ectatic corneas. Yagi-Yaguchi et al., in `their retrospective study, reported that a large amount of HOAs in LCD when compared with other dystrophies.[13] Recognizing and addressing these symptoms early can significantly improve quality of life for individuals with LCD. There are limited studies on LCD and SL. This case report aims to deliver that SLs are an excellent management option for individuals with LCD, particularly when visual distortions and corneal irregularities cannot be adequately corrected with glasses or standard contact lenses. These large-diameter lenses vault over the cornea and rest on the sclera, offering unique benefits for those with LCD. SL creates a smooth, uniform optical surface that compensates for these irregularities, improving visual clarity and reducing distortions. The custom design of SL minimizes refractive errors and light scatter caused by corneal deposits, enhancing vision quality by reducing HOAs. SL protects the cornea by creating a FR between the lens and the cornea. This FR promotes healing, prevents further damage, and reduces the chances of recurrent corneal erosions, also keeping the cornea hydrated, reducing symptoms of dryness and irritation.
CONCLUSION
SL provides excellent symptom management and visual improvement, they are not a cure for LCD. They should be part of a comprehensive treatment plan that may also include lubricating drops, treatment for recurrent erosions, or surgical interventions (e.g., phototherapeutic keratectomy or corneal transplant) in advanced cases. Regular follow-ups with an ophthalmologist or contact lens specialist are essential to monitor both the progression of LCD and the fit and function of the SL.
Author contributions:
MB: Solely responsible for conceptualization, manuscript writing, review, editing, and approval of the final version.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understands that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- The molecular genetics of the corneal dystrophies--current status. Front Biosci. 2003;8:d687-713.
- [CrossRef] [PubMed] [Google Scholar]
- IC3D classification of corneal dystrophies--edition 2 In: Cornea. Vol 34. 2015. p. :117-59.
- [CrossRef] [PubMed] [Google Scholar]
- Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet. 1997;15:247-51.
- [CrossRef] [PubMed] [Google Scholar]
- Survey of patients with granular, lattice, avellino, and Reis-Bücklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch Ophthalmol. 2001;119:16-22.
- [Google Scholar]
- TGFBI gene mutations in corneal dystrophies. Hum Mutat. 2006;27:615-25.
- [CrossRef] [PubMed] [Google Scholar]
- Anterior segment optical coherence tomography for the diagnosis of corneal dystrophies according to the IC3D classification. Surv Ophthalmol. 2018;63:365-80.
- [CrossRef] [PubMed] [Google Scholar]
- Functional and visual improvement with prosthetic replacement of the ocular surface ecosystem scleral lenses for irregular corneas. Cornea. 2013;32:1540-3.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical outcomes of scleral misa lenses for visual rehabilitation in patients with pellucid marginal degeneration. Cont Lens Anterior Eye. 2016;39:420-4.
- [CrossRef] [PubMed] [Google Scholar]
- Visual performance of scleral lenses and their impact on quality of life in patients with irregular corneas. Arq Bras Oftalmol. 2018;81:475-80.
- [CrossRef] [PubMed] [Google Scholar]
- Fitting tips and visual rehabilitation of irregular cornea with a new design of corneoscleral contact lens: Objective and subjective evaluation. J Ophthalmol. 2018;2018:3923170.
- [CrossRef] [PubMed] [Google Scholar]
- The effect of scleral lenses on vision, refraction and aberrations in post-LASIK ectasia, keratoconus and pellucid marginal degeneration. Ophthalmic Physiol Opt. 2021;41:664-72.
- [CrossRef] [PubMed] [Google Scholar]
- Corneal higher order aberrations in granular, lattice and macular corneal dystrophies. PLoS One. 2016;11:e0161075.
- [CrossRef] [PubMed] [Google Scholar]
